These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 22720779
1. Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study. Gündüz T, Emir Ö, Kürtüncü M, Mutlu M, Tumaç A, Akca S, Coban O, Bahar S, Öktem-Tanör Ö, Tüzün E, Eraksoy M, Gürvit H, Akman-Demir G. Int J Neurosci; 2012 Nov; 122(11):650-6. PubMed ID: 22720779 [Abstract] [Full Text] [Related]
2. Cognitive functioning in Behçet's disease. Cavaco S, da Silva AM, Pinto P, Coutinho E, Santos E, Bettencourt A, Pinto C, Gonçalves A, Silva S, Gomes F, Carvalho L, Pereira C, Martins B, Correia J, Vasconcelos C. Ann N Y Acad Sci; 2009 Sep; 1173():217-26. PubMed ID: 19758154 [Abstract] [Full Text] [Related]
3. Executive dysfunctions and depression in Behçet's disease without explicit neurological involvement. Erberk-Ozen N, Birol A, Boratav C, Kocak M. Psychiatry Clin Neurosci; 2006 Aug; 60(4):465-72. PubMed ID: 16884449 [Abstract] [Full Text] [Related]
4. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia. Houman MH, Bellakhal S, Ben Salem T, Hamzaoui A, Braham A, Lamloum M, Monia SK, Ben Ghorbel I. Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180 [Abstract] [Full Text] [Related]
5. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N. Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589 [Abstract] [Full Text] [Related]
6. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A. J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420 [Abstract] [Full Text] [Related]
7. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors. Farahangiz S, Sarhadi S, Safari A, Borhani-Haghighi A. Int J Rheum Dis; 2012 Dec 15; 15(6):e142-9. PubMed ID: 23253242 [Abstract] [Full Text] [Related]
8. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis]. Aldrete Cortez VR, Duriez-Sotelo E, Carrillo-Mora P, Pérez-Zuno JA. Neurologia; 2013 Sep 15; 28(7):394-9. PubMed ID: 23260448 [Abstract] [Full Text] [Related]
9. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173 [Abstract] [Full Text] [Related]
10. Neurological manifestations of Behçet's disease. Borhani-Haghighi A, Samangooie S, Ashjazadeh N, Nikseresht A, Shariat A, Yousefipour G, Safari A. Saudi Med J; 2006 Oct 18; 27(10):1542-6. PubMed ID: 17013480 [Abstract] [Full Text] [Related]
12. Cognitive impairment in Behçet's disease patients without overt neurological involvement. Monastero R, Camarda C, Pipia C, Lopez G, Camarda LK, Baiamonte V, Ferrante A, Triolo G, Camarda R. J Neurol Sci; 2004 May 15; 220(1-2):99-104. PubMed ID: 15140614 [Abstract] [Full Text] [Related]
13. Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Akman-Demir G, Mutlu M, Kiyat-Atamer A, Shugaiv E, Kurtuncu M, Tugal-Tutkun I, Tuzun E, Eraksoy M, Bahar S. Clin Exp Rheumatol; 2015 May 15; 33(6 Suppl 94):S80-4. PubMed ID: 26486298 [Abstract] [Full Text] [Related]
14. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Deloire M, Ruet A, Hamel D, Bonnet M, Brochet B. Mult Scler; 2010 May 15; 16(5):581-7. PubMed ID: 20194578 [Abstract] [Full Text] [Related]
15. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Brochet B, Deloire MS, Bonnet M, Salort-Campana E, Ouallet JC, Petry KG, Dousset V. Mult Scler; 2008 Nov 15; 14(9):1242-9. PubMed ID: 18653737 [Abstract] [Full Text] [Related]
16. Neuro-Behçet's disease presenting as an isolated progressive cognitive and behavioral syndrome. Saracino D, Allegorico L, Barbarulo AM, Pollo B, Giaccone G, D'Amico A, D'Incerti L, Bugiani O, Di Iorio G, Sampaolo S, Melone MAB. Neurocase; 2018 Nov 15; 24(5-6):238-241. PubMed ID: 30583716 [Abstract] [Full Text] [Related]
17. [Dementia following bipolar disorder]. Lebert F, Lys H, Haëm E, Pasquier F. Encephale; 2008 Dec 15; 34(6):606-10. PubMed ID: 19081458 [Abstract] [Full Text] [Related]
18. Cognitive impairment and structural brain damage in benign multiple sclerosis. Rovaris M, Riccitelli G, Judica E, Possa F, Caputo D, Ghezzi A, Bertolotto A, Capra R, Falautano M, Mattioli F, Martinelli V, Comi G, Filippi M. Neurology; 2008 Nov 04; 71(19):1521-6. PubMed ID: 18815387 [Abstract] [Full Text] [Related]
19. Parenchymal Neuro-Behçet's disease or Comorbid Behçet's disease with multiple sclerosis: A discriminative analysis of a complex clinical entity. İsmayılov R, Talibov T, Gündüz T, Kürtüncü M. Mult Scler Relat Disord; 2024 Jul 04; 87():105684. PubMed ID: 38788360 [Abstract] [Full Text] [Related]
20. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group. Mult Scler; 2009 Jul 04; 15(7):779-88. PubMed ID: 19542262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]